Accepted for Publication: October 15, 2014.
Published Online: February 11, 2015. doi:10.1001/jamadermatol.2014.4409.
Study concept and design: Grabell, Yancey, Chong.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Grabell, Chong.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Grabell, Chong.
Obtained funding: Yancey, Chong.
Administrative, technical, or material support: Matthews, Yancey, Chong.
Study supervision: Chong.
Conflict of Interest Disclosures: Dr Chong reported being an investigator for Daavlin Corporation. Dr Yancey reported serving on advisory boards for Stiefel/GlaxoSmithKline and Mary Kay, Inc. No other disclosures were reported.
Funding/Support: This study was supported in part by grant K23AR061441 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Texas Southwestern Medical Center and its affiliated academic and health care centers, the National Center for Research Resources, and the National Institutes of Health.
Additional Contributions: Rose Cannon (Department of Dermatology, University of Texas Southwestern Medical Center) provided administrative support in the preparation of the manuscript.